Business Description
Aster DM Healthcare Ltd
ISIN : INE914M01019
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.37 | |||||
Debt-to-EBITDA | 3.34 | |||||
Interest Coverage | 2.38 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.02 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.7 | |||||
3-Year EBITDA Growth Rate | 10.5 | |||||
3-Year EPS without NRI Growth Rate | 13.3 | |||||
3-Year FCF Growth Rate | 11.7 | |||||
3-Year Book Growth Rate | 10.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.16 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.16 | |||||
9-Day RSI | 21.13 | |||||
14-Day RSI | 28.24 | |||||
6-1 Month Momentum % | 24.15 | |||||
12-1 Month Momentum % | 65.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.97 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 124.69 | |||||
Days Sales Outstanding | 62.35 | |||||
Days Payable | 270.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -4.27 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.95 | |||||
Operating Margin % | 6.96 | |||||
Net Margin % | 2.4 | |||||
FCF Margin % | 7.3 | |||||
ROE % | 7.5 | |||||
ROA % | 2.2 | |||||
ROIC % | 6.26 | |||||
ROC (Joel Greenblatt) % | 10.53 | |||||
ROCE % | 9.03 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 55.15 | |||||
PE Ratio without NRI | 50.07 | |||||
Price-to-Owner-Earnings | 25.12 | |||||
PEG Ratio | 3.21 | |||||
PS Ratio | 1.32 | |||||
PB Ratio | 4.08 | |||||
Price-to-Tangible-Book | 6.16 | |||||
Price-to-Free-Cash-Flow | 18.14 | |||||
Price-to-Operating-Cash-Flow | 9.75 | |||||
EV-to-EBIT | 25.12 | |||||
EV-to-EBITDA | 12.62 | |||||
EV-to-Revenue | 1.68 | |||||
EV-to-FCF | 23.54 | |||||
Price-to-Projected-FCF | 1.75 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.24 | |||||
Price-to-Graham-Number | 3.87 | |||||
Earnings Yield (Greenblatt) % | 3.98 | |||||
FCF Yield % | 5.69 | |||||
Forward Rate of Return (Yacktman) % | 18.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aster DM Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 135,049.3 | ||
EPS (TTM) (₹) | 6.51 | ||
Beta | 1.27 | ||
Volatility % | 26.97 | ||
14-Day RSI | 28.24 | ||
14-Day ATR (₹) | 24.996617 | ||
20-Day SMA (₹) | 444.19 | ||
12-1 Month Momentum % | 65.95 | ||
52-Week Range (₹) | 238.9 - 558.3 | ||
Shares Outstanding (Mil) | 497.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aster DM Healthcare Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aster DM Healthcare Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aster DM Healthcare Ltd Frequently Asked Questions
What is Aster DM Healthcare Ltd(BOM:540975)'s stock price today?
When is next earnings date of Aster DM Healthcare Ltd(BOM:540975)?
Does Aster DM Healthcare Ltd(BOM:540975) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |